{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:28:58Z","timestamp":1786984138740,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ahjo.2021.100044","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T02:50:53Z","timestamp":1629859853000},"page":"100044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["STEMI care 2021: Addressing the knowledge gaps"],"prefix":"10.1016","volume":"11","author":[{"given":"Mehmet","family":"Yildiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer R.","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ahjo.2021.100044_bb0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCULATIONAHA.112.114140","article-title":"From concept to reality: a decade of progress in regional ST-elevation myocardial infarction systems","volume":"126","author":"Henry","year":"2012","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ahjo.2021.100044_bb0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCULATIONAHA.115.019474","article-title":"Regional systems of care demonstration project: american heart association mission: lifeline STEMI systems accelerator","volume":"134","author":"Jollis","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ahjo.2021.100044_bb0015","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/CIRCULATIONAHA.117.032446","article-title":"Impact of regionalization of ST-segment-elevation myocardial infarction care on treatment times and outcomes for emergency medical services-transported patients presenting to hospitals with percutaneous coronary intervention: mission: lifeline accelerator","volume":"137","author":"Jollis","year":"2018","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ahjo.2021.100044_bb0020","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/CIRCULATIONAHA.107.694141","article-title":"A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction","volume":"116","author":"Henry","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ahjo.2021.100044_bb0025","first-page":"415","article-title":"Implementation of regional ST-segment elevation myocardial infarction systems of care: successes and challenges","volume":"5","author":"Fordyce","year":"2016","journal-title":"Interv. Cardiol. Clin."},{"issue":"1","key":"10.1016\/j.ahjo.2021.100044_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008096","article-title":"Improving Care of STEMI in the United States 2008 to 2012","volume":"8","author":"Granger","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ahjo.2021.100044_bb0035","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000959","article-title":"Invasive management of acute myocardial infarction complicated by cardiogenic shock: a scientific statement from the American Heart Association","author":"Henry","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ahjo.2021.100044_bb0040","first-page":"844","article-title":"SCAI expert consensus statement on out of hospital cardiac arrest","volume":"96","author":"Lotfi","year":"2020","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"11","key":"10.1016\/j.ahjo.2021.100044_bb0045","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/CIRCULATIONAHA.113.005568","article-title":"ST-elevation myocardial infarction diagnosed after hospital admission","volume":"129","author":"Garberich","year":"2014","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.ahjo.2021.100044_bb0050","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1016\/j.jacc.2020.04.011","article-title":"Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic","volume":"75","author":"Garcia","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.ahjo.2021.100044_bb0055","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2020.04.039","article-title":"Management of Acute Myocardial Infarction during the COVID-19 pandemic: a position statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the american College of Cardiology (ACC), and the american College of Emergency Physicia","volume":"76","author":"Mahmud","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1 Pt B","key":"10.1016\/j.ahjo.2021.100044_bb0060","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcin.2014.07.017","article-title":"Increasing percutaneous coronary interventions for ST-segment elevation myocardial infarction in the United States: progress and opportunity","volume":"8","author":"Shah","year":"2015","journal-title":"JACC. Cardiovasc. Interv."},{"issue":"8","key":"10.1016\/j.ahjo.2021.100044_bb0065","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa025142","article-title":"A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction","volume":"349","author":"Andersen","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ahjo.2021.100044_bb0070","first-page":"427","article-title":"Time to treatment: focus on transfer in ST-elevation myocardial infarction","volume":"5","author":"Russo","year":"2016","journal-title":"Interv. Cardiol. Clin."},{"issue":"4","key":"10.1016\/j.ahjo.2021.100044_bb0075","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"61","author":"O\u2019Gara","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ahjo.2021.100044_bb0080","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000370","article-title":"Growth in percutaneous coronary intervention capacity relative to population and disease prevalence","volume":"2","author":"Langabeer","year":"2013","journal-title":"J. Am. Heart Assoc."},{"issue":"10","key":"10.1016\/j.ahjo.2021.100044_bb0085","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/eurheartj\/ehr403","article-title":"Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural ST-elevation myocardial infarction patients with expected delays due to long-distance transfers","volume":"33","author":"Larson","year":"2012","journal-title":"Eur. Heart J."},{"issue":"15","key":"10.1016\/j.ahjo.2021.100044_bb0090","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIRCULATIONAHA.111.033118","article-title":"Causes of delay and associated mortality in patients transferred with ST-segment-elevation myocardial infarction","volume":"124","author":"Miedema","year":"2011","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ahjo.2021.100044_bb0095","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1001\/jama.298.23.2754","article-title":"\u2018False-positive\u2019 cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction","volume":"298","author":"Larson","year":"2007","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ahjo.2021.100044_bb0100","first-page":"451","article-title":"False activations for ST-segment elevation myocardial infarction","volume":"5","author":"Lange","year":"2016","journal-title":"Interv. Cardiol. Clin."},{"key":"10.1016\/j.ahjo.2021.100044_bb0105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.carrev.2020.08.019","article-title":"The Midwest ST-elevation myocardial infarction consortium: design and rationale","volume":"23","author":"Yildiz","year":"2021","journal-title":"Cardiovasc. Revasc. Med."},{"issue":"16","key":"10.1016\/j.ahjo.2021.100044_bb0110","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ahjo.2021.100044_bb0115","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ahjo.2021.100044_bb0120","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jcin.2020.04.004","article-title":"Clinical characteristics and outcomes of STEMI patients with cardiogenic shock and cardiac arrest","volume":"13","author":"Omer","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"issue":"21","key":"10.1016\/j.ahjo.2021.100044_bb0125","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.295.21.2511","article-title":"Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction","volume":"295","author":"Hochman","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ahjo.2021.100044_bb0130","first-page":"29","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the american College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the societ","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"9","key":"10.1016\/j.ahjo.2021.100044_bb0135","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.006692","article-title":"Understanding how cardiac arrest complicates the analysis of clinical trials of cardiogenic shock","volume":"13","author":"Jentzer","year":"2020","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"10265","key":"10.1016\/j.ahjo.2021.100044_bb0140","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(20)32338-2","article-title":"Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single Centre, open-label, randomised controlled trial","volume":"396","author":"Yannopoulos","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.ahjo.2021.100044_bb0145","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jacc.2015.05.009","article-title":"Cardiac arrest: a treatment algorithm for emergent invasive cardiac procedures in the resuscitated comatose patient","volume":"66","author":"Rab","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ahjo.2021.100044_bb0150","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/CIRCULATIONAHA.110.986257","article-title":"Therapeutic hypothermia after out-of-hospital cardiac arrest: evaluation of a regional system to increase access to cooling","volume":"124","author":"Mooney","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahjo.2021.100044_bb0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the european socie","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ahjo.2021.100044_bb0160","first-page":"439","article-title":"Reperfusion options for ST elevation myocardial infarction patients with expected delays to percutaneous coronary intervention","volume":"5","author":"Larson","year":"2016","journal-title":"Interv. Cardiol. Clin."},{"issue":"15","key":"10.1016\/j.ahjo.2021.100044_bb0165","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJMoa1301092","article-title":"Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction","volume":"368","author":"Armstrong","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.ahjo.2021.100044_bb0170","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.jacc.2019.03.011","article-title":"Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis: TREAT trial","volume":"73","author":"Berwanger","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ahjo.2021.100044_bb0175","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jamacardio.2017.5356","article-title":"In-hospital ST-segment elevation myocardial infarction: improving diagnosis, triage, and treatment","volume":"3","author":"Levine","year":"2018","journal-title":"JAMA Cardiol."},{"issue":"6515","key":"10.1016\/j.ahjo.2021.100044_bb0180","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.abe2813","article-title":"COVID-19 can affect the heart","volume":"370","author":"Topol","year":"2020","journal-title":"Science (80-.)"},{"issue":"5","key":"10.1016\/j.ahjo.2021.100044_bb0185","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jacbts.2020.04.002","article-title":"COVID-19 for the cardiologist: basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies","volume":"5","author":"Atri","year":"2020","journal-title":"JACC. Basic Transl. Sci."},{"issue":"10","key":"10.1016\/j.ahjo.2021.100044_bb0190","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jacc.2020.06.068","article-title":"Cardiac troponin for assessment of myocardial injury in COVID-19: JACC review topic of the week","volume":"76","author":"Sandoval","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ahjo.2021.100044_bb0195","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019958","article-title":"Value of registries in ST-segment-elevation myocardial infarction Care in both the pre-coronavirus disease 2019 and the coronavirus disease 2019 eras","volume":"10","author":"Brindis","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"20","key":"10.1016\/j.ahjo.2021.100044_bb0200","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.jacc.2020.09.596","article-title":"Delay, death, and heterogeneity of primary PCI during the COVID-19 pandemic: an international perspective","volume":"76","author":"Park","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"21","key":"10.1016\/j.ahjo.2021.100044_bb0205","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMsb2005114","article-title":"Fair allocation of scarce medical resources in the time of Covid-19","volume":"382","author":"Emanuel","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ahjo.2021.100044_bb0210","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2020.06.039","article-title":"Management and outcomes of patients with STEMI during the COVID-19 pandemic in China","volume":"76","author":"Xiang","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"20","key":"10.1016\/j.ahjo.2021.100044_bb0215","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.jacc.2020.09.546","article-title":"Impact of COVID-19 pandemic on mechanical reperfusion for patients with STEMI","volume":"76","author":"De Luca","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ahjo.2021.100044_bb0220","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.006834","article-title":"ST-segment-elevation myocardial infarction care and COVID-19: the value proposition of fibrinolytic therapy and the pharmacoinvasive strategy","volume":"13","author":"Bainey","year":"2020","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"19","key":"10.1016\/j.ahjo.2021.100044_bb0225","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1093\/eurheartj\/ehaa266","article-title":"Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by \u2018on the scene\u2019 cardiologists","volume":"41","author":"Zhang","year":"2020","journal-title":"Eur. Heart J."},{"issue":"22","key":"10.1016\/j.ahjo.2021.100044_bb0230","article-title":"Impact of coronavirus disease 2019 pandemic on the incidence and management of out-of-hospital cardiac arrest in patients presenting with acute myocardial infarction in England","volume":"9","author":"Hons","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"10","key":"10.1016\/j.ahjo.2021.100044_bb0235","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jaccas.2020.07.011","article-title":"\u2018Back to the future\u2019 for STEMI?: The COVID-19 experience","volume":"2","author":"Riley","year":"2020","journal-title":"JACC. Case Rep."},{"issue":"February","key":"10.1016\/j.ahjo.2021.100044_bb0240","article-title":"ST-segment elevation in patients with COVID-19: a systematic review","author":"Diaz-Arocutipa","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"issue":"16","key":"10.1016\/j.ahjo.2021.100044_bb0245","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.jacc.2021.02.055","article-title":"Initial findings from the north american COVID-19 myocardial infarction registry","volume":"77","author":"Garcia","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ahjo.2021.100044_bb0250","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1161\/CIRCULATIONAHA.120.048180","article-title":"Temporary emergency guidance to STEMI systems of care during the COVID-19 pandemic: AHA\u2019s mission: lifeline","volume":"142","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2021.100044_bb0255","article-title":"dAdapting STEMI care for the COVID-19 pandemic: the case for low-risk STEMI triage and early discharge","author":"Lopez","year":"2020","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"4","key":"10.1016\/j.ahjo.2021.100044_bb0260","first-page":"481","article-title":"Optimal antiplatelet therapy in ST-segment elevation myocardial infarction","volume":"5","author":"Harari","year":"2016","journal-title":"Interv. Cardiol. Clin."},{"issue":"6","key":"10.1016\/j.ahjo.2021.100044_bb0265","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrcardio.2017.18","article-title":"Antithrombotic therapy for patients with STEMI undergoing primary PCI","volume":"14","author":"Franchi","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"issue":"10","key":"10.1016\/j.ahjo.2021.100044_bb0270","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jcin.2016.02.013","article-title":"Optimal P2Y12 inhibitor in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a network meta-analysis","volume":"9","author":"Rafique","year":"2016","journal-title":"JACC. Cardiovasc. Interv."},{"key":"10.1016\/j.ahjo.2021.100044_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2017.09.018","article-title":"Thrombus aspiration and prehospital ticagrelor administration in ST-elevation myocardial infarction: findings from the ATLANTIC trial","volume":"196","author":"Kilic","year":"2018","journal-title":"Am. Heart J."},{"issue":"8","key":"10.1016\/j.ahjo.2021.100044_bb0280","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1055\/s-0038-1666862","article-title":"Fentanyl delays the platelet inhibition effects of oral ticagrelor: full report of the PACIFY randomized clinical trial","volume":"118","author":"Ibrahim","year":"2018","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.ahjo.2021.100044_bb0285","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/eurheartj\/ehv547","article-title":"Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial","volume":"37","author":"Kubica","year":"2016","journal-title":"Eur. Heart J."},{"issue":"21","key":"10.1016\/j.ahjo.2021.100044_bb0290","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without aspirin in high-risk patients after PCI","volume":"381","author":"Mehran","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.ahjo.2021.100044_bb0295","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/jama.2020.7580","article-title":"Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO randomized clinical trial","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ahjo.2021.100044_bb0300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0091270009344986","article-title":"Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: a direct, parenteral P2Y12 receptor antagonist","volume":"50","author":"Akers","year":"2010","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ahjo.2021.100044_bb0305","first-page":"39","article-title":"Cangrelor: pharmacology, clinical data, and role in percutaneous coronary intervention","volume":"6","author":"Price","year":"2017","journal-title":"Interv. Cardiol. Clin."},{"issue":"14","key":"10.1016\/j.ahjo.2021.100044_bb0310","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/CIRCULATIONAHA.118.038317","article-title":"Platelet inhibition with cangrelor and crushed ticagrelor in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"139","author":"Franchi","year":"2019","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.ahjo.2021.100044_bb0315","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect of platelet inhibition with cangrelor during PCI on ischemic events","volume":"368","author":"Bhatt","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ahjo.2021.100044_bb0320","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ahjo.2021.100044_bb0325","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/s-0030-1267856","article-title":"Review of currently available GP IIb\/IIIa inhibitors and their role in peripheral vascular interventions","volume":"27","author":"Stangl","year":"2010","journal-title":"Semin. Intervent. Radiol."},{"issue":"3","key":"10.1016\/j.ahjo.2021.100044_bb0330","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.amjcard.2019.05.010","article-title":"Comparison of routine versus selective glycoprotein IIb\/IIIa inhibitors usage in primary percutaneous coronary intervention (from the british cardiovascular interventional Society)","volume":"124","author":"Orzalkiewicz","year":"2019","journal-title":"Am. J. Cardiol."}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602221000422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602221000422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:28:18Z","timestamp":1763000898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602221000422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":66,"alternative-id":["S2666602221000422"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2021.100044","relation":{},"ISSN":["2666-6022"],"issn-type":[{"value":"2666-6022","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"STEMI care 2021: Addressing the knowledge gaps","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2021.100044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100044"}}